Latest News about VCEL
Recent news which mentions VCEL
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
January 22, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 21, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
From Benzinga
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
January 15, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 14, 2021
From Benzinga
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
January 13, 2021
From Benzinga
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
January 13, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Friday
January 08, 2021
From Benzinga
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
January 08, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 07, 2021
From Benzinga
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
January 07, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 31, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 30, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
December 29, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 28, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 24, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 23, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 22, 2020
From Benzinga
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
December 22, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 18, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 18, 2020
December 18, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 11, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
December 11, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod
December 02, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 01, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.